Negative pregnancy test (no more than 2 days before enrolment) and adequate contraception during the study in women of child bearing potential (pre- menopausal, <2 years post-menopausal or not surgically sterile)

Exclusion Criteria:

Any anti-CD20 and / or any other anti-T cell directed antibody treatments < 3 months before application of FBTA05

Positivity for human anti-mouse antibodies (HAMAs)

History of GvHD ° III or IV, or GvHD requiring steroid therapy with more than 10 mg/day

Known or suspected hypersensitivity to recombinant, murine or rat proteins

Any condition which in the judgement of the Investigator would place the subject at undue risk or interfere with the results of the study

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01138579